Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Statins in the prevention of myocardial damage in pneumonia
2013-002799-42Phase 4Active
- Sponsor
- Azienda Ospedaliero-Universitaria Policlinico Umberto I
- Start
- Dec 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of atorvastatin in community-acquired pneumonia (CAP), cardiac morbidity, myocardial infarction (MI) and 3 more, sponsored by Azienda Ospedaliero-Universitaria Policlinico Umberto I. Primary endpoint: Primary composite cardiovascular endpoint. Started Dec 2013; status: active.
02
Drugs
atorvastatin
03
Conditions
community-acquired pneumonia (CAP)cardiac morbiditymyocardial infarction (MI)heart failure (HF)arrhythmia
Beyond the preview
Go deeper on 2013-002799-42.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-002799-42.